Literature DB >> 29493025

Comparative Photothermal Performance among Various Sub-Stoichiometric 2D Oxygen-Deficient Molybdenum Oxide Nanoflakes and In Vivo Toxicity.

Sunil Pandey1, Krishna Hari Sharma2, Amit Kumar Sharma2, Yowan Nerthigan2, Da-Ren Hang2, Hui-Fen Wu1,3,4,5.   

Abstract

The present study deals with photothermal therapy of solid tumors using different forms of oxygen-deficient sub-stoichiometric two-dimensional (2D) molybdenum oxide nanoflakes (α-MoO3-x ). Upon exfoliation of molybdenum oxide power using fine gridding followed by ultrasonication, bluish green molybdenum oxide (BG α-MoO3 ) was obtained. Oxygen vacancies in BG were generated upon irradiation with an intense xenon lamp. Irradiating the BG for 3 and 5 h, deep blue (B) and olive green (G) oxygen-deficient nanoflakes were obtained respectively. All exhibited high NIR absorption, making these nanomaterials suitable for photothermal therapy. All three forms were functionalized with polypyrrole (PPy@BG, PPy@B, PPy@G) to boost the photothermal stability and transduction efficiency. After functionalization and irradiation with 808 nm laser, the enhancement of temperature for BG, B, G was 50, 65, 52 °C respectively and the corresponding photothermal transduction efficiencies (PTE) were 29.32, 44.42 and 42.00 %. Each of the nanoflakes were found to be highly biocompatible and photostable both in vitro and in vivo. There was substantial decrease in the size of tumors after seven days of treatment on tumor-bearing experimental mice models.
© 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  nanostructures; oxygen-deficient; photostability; polypyrrole; xenon lamp

Year:  2018        PMID: 29493025     DOI: 10.1002/chem.201705734

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  1 in total

Review 1.  Impact of Molybdenum Compounds as Anticancer Agents.

Authors:  Ayodele T Odularu; Peter A Ajibade; Johannes Z Mbese
Journal:  Bioinorg Chem Appl       Date:  2019-09-10       Impact factor: 7.778

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.